OGDEN, Utah--(BUSINESS WIRE)--Setpoint Systems (http://www.setpointusa.com), a leader in design and manufacture of custom lean automation solutions and manufacturing ...

The MarketWatch News Department was not involved in the creation of this content. Milestone underscores continued momentum in commercial rollout and accelerating adoption of neuroimmune modulation as ...

Northwell Health was one of many who conducted a pioneering clinical trial to treat rheumatoid arthritis through a chip implanted on the vagus nerve. The first technology of its kind yielded ...

Credit: SetPoint Medical. The SetPoint System is a rechargeable neurostimulation device that is implanted on the vagus nerve. Treatment with the SetPoint System, a neuroimmune modulation device, was ...

The U.S. Food and Drug Administration has approved the SetPoint System, a neuroimmune modulation device for the treatment of adults living with moderate-to-severe rheumatoid arthritis (RA). The ...

"This analysis provides compelling evidence that the SetPoint System delivers both clinical benefit to those with RA and meaningful economic value to the healthcare system," said Murthy Simhambhatla, ...

SALT LAKE CITY–(BUSINESS WIRE)–D.A. Davidson & Co. announced today that it served as exclusive financial advisor to both Setpoint Systems, a leading provider of automation solutions, and Setpoint, Inc ...

PENSACOLA, FL, UNITED STATES, April 22, 2026 /EINPresswire.com/ — Lovell ® Government Services and SetPoint Medical, a commercial-stage medical technology company ...

Procedures performed by Dr. Webster Crowley mark a milestone for neuroimmune modulation therapy in the Midwest SetPoint Medical today announced the first patients in Chicago have been treated with the ...

Milestone underscores continued momentum in commercial rollout and accelerating adoption of neuroimmune modulation as a new option for adults living with Rheumatoid Arthritis "The SetPoint System ...